Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2011

Mar 1, 2011

32337_dirs_2011-03-01_1d64c2b1-e89d-45e4-baf5-ba2d81255d5d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2011-02-27

Reporting Person: JOHNSON MICHAEL (Director, Chairman & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-27 Common Stock F 7032 $78.20 Disposed 359664 Direct
2011-02-28 Common Stock F 7213 $78.41 Disposed 352451 Direct
2011-03-01 Common Stock M 122061 $10.56 Acquired 474512 Direct
2011-03-01 Common Stock S 42646 $75.25 Disposed 431866 Direct
2011-03-01 Common Stock S 42200 $76.32 Disposed 389666 Direct
2011-03-01 Common Stock S 5499 $76.99 Disposed 384167 Direct
2011-03-01 Common Stock S 4901 $77.91 Disposed 379266 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-03-01 Non-Qualified Stock Options (Right to Buy) $10.56 M 122061 Disposed 2013-04-03 Common Stock (122061) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 55000 Indirect
Common Stock 55000 Indirect
Common Stock 56561 Indirect

Footnotes

F1: Pursuant to the Issuer's 2005 Stock Incentive Plan and the terms of the related award agreement, shares of the Issuer's common stock are issued to the Reporting Person as his restricted stock units vest, with a portion of the newly issued shares automatically withheld by the Issuer to satisfy the resulting withholding tax obligation. This Statement of Changes of Beneficial Ownership has been filed to reflect that withholding of shares due to a recent vesting of restricted stock units held by the Reporting Person. The withholding of the newly issued shares occurred automatically upon the vesting of the restricted stock units, and as such, no investment decision was made by the Reporting Person in connection with this transfer.

F2: Sale made pursuant to a pre-existing 10b5-1(c) trading plan publicly disclosed by the Issuer on November 9, 2009, under the headline "Herbalife Chairman and CEO Implements Orderly Stock Trading Plan; Will Retain Half of Net Proceeds in Company Stock."

F3: This transaction was executed in multiple trades at prices ranging from $74.73 to $75.69. The price reported reflects the weighted average sale price of $75.25. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was
effected.

F4: This transaction was executed in multiple trades at prices ranging from $75.73 to $76.71. The price reported reflects the weighted average sale price of $76.32. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was
effected.

F5: This transaction was executed in multiple trades at prices ranging from $76.73 to $77.67. The price reported reflects the weighted average sale price of $76.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was
effected.

F6: This transaction was executed in multiple trades at prices ranging from $77.73 to $77.93. The price reported reflects the weighted average sale price of $77.91. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was
effected.

F7: These options were fully vested as of June 20, 2008.